Drug Monitoring Assess Panel, Extended, Quantitative, Urine

Test code

39992

CPT code(s)*

80324, 80346, 80353, 80354, 80356, 80361, 80365, 80348, 80362, 80358, 80359, 80323, 80357, 80369, 80355, 80360, 83992, 80366, 80372, 80373, 80335, 80368 (HCPCS: G0483)

**CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.

Not offered in Quest Diagnostics Nichols Institute (IFD) – San Juan Capistrano. Please provide Service Area Information to find available tests you can order.

In-home collection may be available in your area for purchase through Quest Mobile.

Clinical significance

Drug Monitoring Assess Panel, Extended, Quantitative, Urine - A single direct to definitive panel with the ability to identify multiple specific drugs and metabolites across drug classes facilitates enhanced patient care. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not…

Test resources

Test summary

Drug Monitoring, Assess Panels, Quantitative, Urine

Details

Test details

Includes

If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.

If this test code is not ordered with 39158, all medMATCH result codes will be DNR'd.

Amphetamines, Benzodiazepines, Buprenorphine and Naloxone, Carisoprodol Metabolite, Cocaine Metabolite, Fentanyl, Gabapentin, Heroin Metabolite, Ketamine, MDMA/MDA, Methadone Metabolite, Methylphenidate Metabolite, Mitragynine, Naltrexone, Opiates Expanded, Phencyclidine, Pregabalin, Tapentadol, Tramadol, Tricyclic Antidepressants, Zolpidem
Specimen validity consisting of Creatinine, Oxidant, and pH testing.

Methodology

Mass Spectrometry (MS)

Assay category

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Specimen requirements
Patient preparation	None Specified
Preferred specimen(s)	10 mL random urine collected in a plastic urine container
Minimum volume	9 mL
Transport container	Plastic urine container
Transport temperature	Room temperature
Specimen stability	Room temperature: 5 days Refrigerated: 7 days Frozen: 30 days
Reject criteria	Preserved samples

Reference range(s)

See Laboratory Report

LOINC® codes

Select a service areato view this section

Service Area Information

Performing lab & setup schedule

Select a service areato view this section

Service Area Information

Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.

*The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.

The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.

Customize the test information for your service area